IL141775A0 - Aglyco products and methods of use - Google Patents

Aglyco products and methods of use

Info

Publication number
IL141775A0
IL141775A0 IL14177599A IL14177599A IL141775A0 IL 141775 A0 IL141775 A0 IL 141775A0 IL 14177599 A IL14177599 A IL 14177599A IL 14177599 A IL14177599 A IL 14177599A IL 141775 A0 IL141775 A0 IL 141775A0
Authority
IL
Israel
Prior art keywords
glycoconjugates
methods
aglyco
aglyco products
products
Prior art date
Application number
IL14177599A
Other languages
English (en)
Inventor
Samuel Bogoch
Elenore S Bogoch
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of IL141775A0 publication Critical patent/IL141775A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Neurology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
IL14177599A 1998-09-04 1999-08-30 Aglyco products and methods of use IL141775A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/146,755 US6242578B1 (en) 1994-02-17 1998-09-04 Aglyco products and methods of use
PCT/US1999/019836 WO2000018351A2 (fr) 1998-09-04 1999-08-30 Produits aglyco et utilisation de ceux-ci

Publications (1)

Publication Number Publication Date
IL141775A0 true IL141775A0 (en) 2002-03-10

Family

ID=22518867

Family Applications (3)

Application Number Title Priority Date Filing Date
IL14177599A IL141775A0 (en) 1998-09-04 1999-08-30 Aglyco products and methods of use
IL141775A IL141775A (en) 1998-09-04 2001-03-04 Agliko products and their use
IL192679A IL192679A (en) 1998-09-04 2008-07-08 Agliko products and their use

Family Applications After (2)

Application Number Title Priority Date Filing Date
IL141775A IL141775A (en) 1998-09-04 2001-03-04 Agliko products and their use
IL192679A IL192679A (en) 1998-09-04 2008-07-08 Agliko products and their use

Country Status (13)

Country Link
US (4) US6242578B1 (fr)
EP (2) EP1115418B1 (fr)
JP (2) JP2004515202A (fr)
KR (1) KR100451446B1 (fr)
CN (2) CN1328286C (fr)
AT (1) ATE406175T1 (fr)
AU (1) AU771836B2 (fr)
BR (1) BR9913446A (fr)
CA (1) CA2341763C (fr)
DE (1) DE69939430D1 (fr)
IL (3) IL141775A0 (fr)
NZ (4) NZ510921A (fr)
WO (1) WO2000018351A2 (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7176275B2 (en) * 1998-09-04 2007-02-13 Samuel Bogoch Anthrax and small pox replikins and methods of use
DE10034712A1 (de) * 2000-07-17 2002-02-07 Arimedes Biotechnology Gmbh Verbrückte Glykokonjugate
US7894999B2 (en) 2001-03-27 2011-02-22 Samuel Bogoch Systems and methods for identifying Replikin Scaffolds and uses of said Replikin Scaffolds
KR100906102B1 (ko) * 2001-03-27 2009-07-07 사무엘 보고치 레플리킨 펩타이드 및 그의 이용
US7774144B2 (en) * 2001-10-26 2010-08-10 Samuel Bogoch System and method for identifying complex patterns of amino acids
US7452963B2 (en) * 2001-03-27 2008-11-18 Samuel Bogoch Replikin peptides and antibodies therefore
JP2004535171A (ja) * 2001-03-27 2004-11-25 ボゴーク，サミュエル レプリキンペプチドおよびその使用
US7442761B2 (en) * 2003-06-06 2008-10-28 Samuel Bogoch Replikin peptides and uses thereof
US7420028B2 (en) 2001-03-27 2008-09-02 Samuel Bogoch Replikins and methods of identifying replikin-containing sequences
US7189800B2 (en) * 2001-03-27 2007-03-13 Samuel Bogoch Replikin peptides in rapid replication of glioma cells and in influenza epidemics
EP2348040A1 (fr) * 2001-07-09 2011-07-27 Samuel Bogoch Peptides de replikine et utilisations associées
WO2003005880A2 (fr) 2001-07-09 2003-01-23 Samuel Bogoch Les peptides 'replikines' et leurs utilisations
US7306919B1 (en) 2001-10-31 2007-12-11 Thornthwaite Jerry T Antigen-antibody cancer recognition system
WO2004073864A2 (fr) * 2003-02-13 2004-09-02 Becton, Dickinson And Company Dispositifs de retrait de composants au cours d'une prise de sang et utilisations correspondantes
US8494781B2 (en) 2003-06-06 2013-07-23 Samuel Bogoch Systems and methods for identifying replikin scaffolds and uses of said replikin scaffolds
US9254315B2 (en) 2004-04-28 2016-02-09 Samuel Bogoch Systems and methods for identifying replikin scaffolds and uses of said replikin scaffolds
US9002652B1 (en) * 2005-01-27 2015-04-07 Institute For Systems Biology Methods for identifying and using organ-specific proteins in blood
EP1859063A4 (fr) 2005-02-16 2012-02-01 Bogoch Samuel Peptides de replikine et utilisations associees
US9820986B2 (en) * 2005-03-04 2017-11-21 Taiwan Hopaz Chems, Mfg. Co., Ltd. Glycopeptide compositions
JP2006288670A (ja) * 2005-04-11 2006-10-26 Terumo Corp カテーテル
EP2092059A4 (fr) * 2006-10-24 2012-03-28 Bogoch Samuel Procede de prediction d'epidemies de grippe
EP2126140A4 (fr) * 2007-01-18 2012-03-28 Samuel Bogoch Procédés permettant de déterminer la létalité d'agents pathogènes et de malignités impliquant des replikin de pointe
WO2008109810A1 (fr) * 2007-03-07 2008-09-12 Cargill, Incorporated Utilisation de glucosamine en tant que substance de récupération d'un stress physique ou mental et d'amélioration de performances
AU2008266702A1 (en) * 2007-05-30 2008-12-24 Elenore S. Bogoch Synthetic replikin peptides against pathogenic infection of invertebrates in aquaculture
US20090269367A1 (en) * 2008-04-23 2009-10-29 Samuel Bogoch Methods and compounds for mitigating pathogenic outbreaks using replikin count cycles
US20100144589A1 (en) * 2008-08-08 2010-06-10 Samuel Bogoch Methods of predicting cancer lethality using replikin counts
US9233148B2 (en) 2009-01-09 2016-01-12 Samuel Bogoch Replikin-based compounds for prevention and treatment of influenza and methods of differentiating infectivity and lethality in influenza
AU2012283914A1 (en) 2011-07-20 2014-01-30 Bogoch, Elanore S. Peptides shared among lethal cancers and therapeutic compositions comprising said peptides

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4298590A (en) * 1975-02-25 1981-11-03 Samuel Bogoch Detection of malignant tumor cells
US4840915A (en) * 1975-02-25 1989-06-20 Brain Research, Inc. Method for diagnosing malignant tumors
US4041146A (en) * 1975-05-01 1977-08-09 General Electric Company Method for detection of biological particles
US4486538A (en) * 1978-07-07 1984-12-04 Samuel Bogoch Detection of malignant tumor cells
US5280113A (en) 1989-08-16 1994-01-18 Monsanto Company Method for producing synthetic N-linked glycoconjugates
GB9202219D0 (en) 1992-02-03 1992-03-18 Connaught Lab A synthetic heamophilus influenzae conjugate vaccine
WO1996032106A1 (fr) * 1995-04-11 1996-10-17 Samuel Bogoch Produits aglyco

Also Published As

Publication number Publication date
AU771836B2 (en) 2004-04-01
US6242578B1 (en) 2001-06-05
US7381411B2 (en) 2008-06-03
US20030023047A1 (en) 2003-01-30
JP2011087589A (ja) 2011-05-06
AU5698699A (en) 2000-04-17
CA2341763A1 (fr) 2000-04-06
EP1990058A1 (fr) 2008-11-12
KR20010072517A (ko) 2001-07-31
NZ544362A (en) 2008-05-30
NZ510921A (en) 2004-09-24
US6638505B2 (en) 2003-10-28
US20080241859A1 (en) 2008-10-02
EP1115418A2 (fr) 2001-07-18
CN1328286C (zh) 2007-07-25
IL192679A0 (en) 2009-02-11
CN101096382A (zh) 2008-01-02
US20040077532A1 (en) 2004-04-22
ATE406175T1 (de) 2008-09-15
KR100451446B1 (ko) 2004-10-06
EP1115418A4 (fr) 2004-06-09
NZ556151A (en) 2009-03-31
CN1324258A (zh) 2001-11-28
DE69939430D1 (de) 2008-10-09
IL192679A (en) 2011-10-31
JP2004515202A (ja) 2004-05-27
BR9913446A (pt) 2004-03-02
NZ533511A (en) 2006-08-31
WO2000018351A3 (fr) 2000-07-13
IL141775A (en) 2008-11-26
WO2000018351A2 (fr) 2000-04-06
EP1115418B1 (fr) 2008-08-27
CA2341763C (fr) 2014-01-21

Similar Documents

Publication Publication Date Title
IL192679A0 (en) Aglyco products and uses thereof
EP0835133A4 (fr) Compositions recombinantes et compositions combinees de virus de la rage et de la variole, et leurs utilisations
BRPI0010612B8 (pt) vacinas
WO2000023955A8 (fr) Particules assimilees a des virus pour l'induction d'anticorps
CA2033640A1 (fr) Vaccins contre le cancer et les maladies infectieuses
BR9814487A (pt) "vacina"
AU7697301A (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
GB2255093A (en) Hiv-1 core protein fragments
IL138424A (en) Covalently reactive antigen analogs and pharmaceutical compositions containing the same
ATE233102T1 (de) Verfahren und zusammensetzung zur umgestaltung multi-epitopischer antigene um die immunantwort einzuleiten
WO2000052165A3 (fr) Compositions et methodes de therapie et de diagnostic du cancer du sein
AU1716297A (en) Patient-specific immunoadsorbers for the extracorporeal apheresis and methods for their preparation
WO1999032634A3 (fr) Compositions derivees de mycobacterium vaccae et leurs methodes d'utilisation
WO1998039034A3 (fr) Utilisation de preparations contenant des anticorps anti-cd44 pour traiter certaines tumeurs et supprimer les reactions immunitaires
EP0868522A4 (fr) Virus de recombinaison combine de la variole et de la peritonite infectieuse du chat, compositions le contenant et leurs procedes d'obtention et d'utilisation
WO2001035989A3 (fr) Nouvelle utilisation d'anticorps en tant que vaccins
WO1999065517A3 (fr) Compositions therapeutiques produisant une reponse immunitaire par renouvellement des antigenes
EP0955366A4 (fr) Proteine antigenique provenant de la malassezia
WO2002041921A3 (fr) Procedes et compositions de protection contre des maladies virales de bovides
WO1999059627A3 (fr) Sous-unite b de verotoxine destinee a une immunisation
BRPI0409321A (pt) antìgeno hìbrido, competição e método para induzir uma resposta imune para um agente infeccioso ou antìgeno de tumor, método para tratar uma doença infecciosa ou cáncer, e, peptìdeo
EP1351967A4 (fr) Compositions et procedes pour la therapie et le diagnostic du cancer des poumons
AU8501191A (en) Cross-reactive influenza a immunization
WO2002048175A3 (fr) Peptides associes a la classe i du complexe majeur d'histocompatibilite et utiles dans la prevention et le traitement de la tuberculose
GB2397018A (en) Combination therapy for treating disease

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed